Wynzora® Cream will be available to US patients from 12 July 2021. CHARLESTON, SC / ACCESSWIRE / July 6, 2021 / EPI Health announced today the publication of two posters featuring data from the head ...

A novel formulation of calcipotriene (CAL), betamethasone dipropionate (BDP) cream was found to be more effective, provide superior quality of life, and safe in patients with psoriasis, compared with ...

– New data analysis from previously completed successful Phase 3 study1 demonstrated WYNZORA® Cream to be effective and convenient for skin of color patients for the treatment of plaque psoriasis ...

Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today the launch of WYNZORA ®, a uniform white aqueous cream containing 0.05 mg/g of ...

Objective: Corticosteroids are effective in controlling the inflammatory component of allergic rhinitis; however, evidence for the clinical efficacy of systemic corticosteroids in this disease is ...

Details concerning the Betamethasone combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

This subgroup analysis shows that skin of color patients treated with CAL/BDP cream have similar efficacy to the total trial population. Patient convenience and satisfaction for CAL/BDP cream were ...